Aims To use the rs1229984 variant associated with alcohol consumption as an instrument for alcohol consumption to test the causality of the association of alcohol consumption with hay fever, asthma, allergic sensitization and serum total immunoglobulin (Ig)E. Design Observational and Mendelian randomization analyses using genetic variants as unbiased markers of exposure to estimate causal effects, subject to certain assumptions. Setting Europe. Participants We included a total of 466 434 people aged 15-82 years from 17 population-based studies conducted from 1997 to 2015.
INTRODUCTION
Alcohol is a strong immune modulating factor [1, 2] . Previous observational studies have shown that moderate and excessive alcohol intake is associated with higher serum levels of total immunoglobulin (Ig)E [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Similarly, alcohol consumption in pregnancy is associated with an increase in cord blood IgE levels from the newborn [14] . Some epidemiological studies have found a positive association between alcohol consumption and allergic sensitization [9, 12] , but other studies have not [6, 8, 15] . Regarding allergic disease, alcohol consumption was positively associated with the risk of developing perennial allergic rhinitis [16] , and alcohol consumption during pregnancy may increase the risk of atopic dermatitis in the offspring [17] . In addition, alcohol is a trigger of hypersensitivity reactions and can cause asthma in genetically predisposed individuals [18] . The possible mechanisms by which alcohol consumption could affect allergic sensitization and levels of total IgE may include a direct effect of alcohol or its metabolites on lymphocyte subsets with subsequent T helper type 1 (Th1)/Th2 cytokine imbalance, or an indirect effect due to alcohol-induced permeability of the gut mucosa to endotoxin of other bacterial products [1, 3, 5, 10, 19] .
Causal inference from conventional epidemiological studies between alcohol consumption and allergic respiratory disease is difficult, due to potential confounding and reverse causation. Mendelian randomization examines causality by using genetic variants, typically single nucleotide polymorphism (SNP), as instruments for exposures. It assumes random allocation of genes from parents to offspring and no direct association between genotype and outcome, and will not be associated with the confounding factors that are inherent in conventional observational studies. The enzyme alcohol dehydrogenase (ADH) oxidizes alcohol to acetaldehyde. The more active forms of this enzyme are protective against drinking, because they cause higher levels of acetaldehyde. In European samples the rs1229984 variant in the ADH1B gene is most strongly associated with alcohol phenotypes, and the protective A-allele frequency is approximately 2-5% in Europeans [20] . The rs1229984 has previously been used as instrument for alcohol consumption in Mendelian randomization studies to examine the effect of alcohol consumption in cardiovascular disease [20] .
People sensitized to inhalant allergens, as measured by serum-specific immunoglobulin E (IgE), are at risk of developing allergic respiratory disease. Serum-specific IgE positivity to inhalant allergens are accepted objective tests of allergic respiratory disease in clinical assessment and in epidemiological studies. The aims of this study were to use the rs1229984 variant as an instrument for alcohol consumption to test the causality of the association of alcohol consumption with (1) hay fever, (2) asthma, (3) allergic sensitization and (4) serum total IgE in a Mendelian randomization meta-analysis of 466 434 participants throughout 17 studies. We examined the effects for everdrinkers and non-drinkers separately.
METHODS

Design
We performed multi-centre traditional observational and Mendelian randomization analyses to determine whether alcohol consumption causally affects allergic respiratory disease and asthma, and estimate the magnitude of the associations. 
Measures
Genotype
Rs1229984 is located in the alcohol dehydrogenase 1B gene (ADH1B). It encodes the ADH1B enzyme that is the main metabolizer of alcohol [20] . Due to the low prevalence of the rs1229984 A-allele, we recoded the genetic variant according to a dominant model into major homozygotes (alcohol-increasing genotype) versus heterozygotes and minor homozygotes combined (alcohol-decreasing genotypes). Description of the method for genotyping within each study is provided in the Supporting information. Genotype frequencies and Hardy-Weinberg equilibrium levels are shown in Supporting information, Table S3 . The minor allele frequency ranged from 0.008 to 0.070 throughout studies. The SNP was directly genotyped in each study, except for the DanFunD study, KORA, the 1936 Cohort, the Rotterdam study and the NEO study (Supporting information).
Hay fever, asthma, allergic sensitization, lung function and serum total IgE Data on hay fever and asthma were obtained from interviews or questionnaires according to Supporting information, Table S4 . Our first choice of definition/diagnosis was life-time/ever, but if not available we used a diagnosis during the past 12 months or longer (Supporting information, Table S4 ). Allergic sensitization was defined by serumspecific IgE positivity to at least one of the tested inhalant allergens (Supporting information, Table S4 ). We used the cut-offs for positivity generally recommended by the manufacturer. Serum total IgE was measured by a number of assays as detailed in the Supporting information, Tables S2 and S4.
Alcohol intake
We used self-reported alcohol status (non-or ever-drinker) and units of alcohol consumed per week (either by interview or questionnaire), reported at the same time or as closely as possible to the assesment of allergic respiratory disease (see Supporting information).
Statistical analyses
Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA), Stata version 12 (StataCorp, College Station, TX, USA), the statistical software R version 3.3.3 (http://www.r-project.org/) and Quanto version 1.2 (University of Southern California, Los Angeles, CA, USA). The P-values are two-tailed, and statistical significance was defined as P < 0.05. Serum total IgE was log-transformed in the regression analyses to fulfil requirements on normality.
With an assumed protective allele frequency of 2% for the rs1229984 genotype, we calculated the required number of cases and controls among ever-drinkers in Quanto 1.2 (University of Southern California) for a range of effect sizes prior to the study. For example, with a power of 0.80 we would need approximately 6000 and 18 000 everdrinkers with and without hay fever, respectively, to detect an odds ratio (OR) of 0.85 and 14 000 and 42 000 everdrinkers with and without hay fever, respectively, to detect an OR of 0.90 among carriers of the protective allele compared to non-carriers. Similarly, for the natural logarithm of serum total IgE [mean = 3.4 and standard deviation (SD) = 1.5] as outcome, we would need approximately 40 000 ever-drinkers to detect an R 2 = 0.0002/ β = À0.10 for carriers versus non-carriers of the protective allele. The sample size needed to estimate an effect on, e.g. hay fever, per genetically determined drink of alcohol with a power of 0.8, type 1 error rate of 0.05, variance in amount of alcohol explained by the SNP of 0.0045 and an OR = 1.3 of hay fever per SD of amount of alcohol, was calculated to be n = 293 025 [21] .
The study was performed as a multi-centre metaanalysis. We provided the study representatives with an invitation to contribute to the study, an analysis protocol and a Stata-script to be used in the analyses. The study results were combined in random-effects meta-analyses. Participants with missing value in one or more variables were excluded. Analyses were performed in all participants and in strata defined by alcohol status. The main analyses were performed in ever-drinkers. The analyses were adjusted for age, gender and genetic principal components if available (British 1958 Birth Cohort, the NEO study and the UK Biobank).
First, observational analyses of the associations of alcohol status and intake with hay fever, asthma, allergic sensitization and serum total IgE were assessed by logistic and linear regression analyses. Secondly, Mendelian randomization analyses were performed. The associations of the alcohol-associated SNP and alcohol status, alcohol intake, hay fever, asthma, allergic sensitization and serum total IgE were assessed using linear and logistic regression. The estimates from each study were meta-analysed using the 'metan' command in Stata. Heterogeneity was examined by the I 2 statistic. The instrumental variable (IV) analyses were performed by the 'MendelianRandomization' package in R using the inverse variance-weighted method ('mr_ivw'), similar to the ratio method for a single IV. These were performed regardless of statistical significance to show the size of the estimates.
As the primary definition of hay fever in the UK Biobank also included eczema, we performed additional analyses using different definitions (Supporting information). A part of the UK Biobank Study, the UK Biobank Lung Exome Variant Evaluation (UK BiLEVE) study, was sampled according to lung function and smoking status, and we performed sensitivity analyses excluding this study (Supporting information). Analyses including UK Biobank data and 1958 BC where the alcohol genotype was directly genotyped, and adjustments made for principal components, are shown in Supporting information, Figs S1-S5.
RESULTS
Descriptive statistics for each of the study populations are shown in Table 1 and Supporting information, Table S1 . Minor allele frequencies and Hardy-Weinberg Equilibrium P-values are shown in Supporting information, Table S3 . There was a statistically significant positive association between the rs1229984 genotype (major homozygotes versus minor homozygotes and heterozygotes) and higher alcohol intake (logarithmically transformed) (Fig. 1) .
Observational analysis
Ever-drinking, but not alcohol intake, was positively associated with hay fever. Ever-drinking, but not alcohol intake, was inversely associated with asthma (Fig. 2) . The observed associations of ever-drinking with hay fever and asthma, respectively, were somewhat consistent throughout studies (Supporting information, Figs S6-S7). For alcohol intake and hay fever and asthma there was some heterogeneity throughout studies (Supporting information, Figs S10-S11). Ever-drinking and alcohol intake were positively, although ever-drinking statistically nonsignificantly, associated with allergic sensitization (Fig. 2) , with low heterogeneity throughout studies (Supporting information, Figs S8 and S12). The number of participants in the analyses of allergic sensitization was substantially lower (n = 19 443-21 213, Fig. 2 ) than for hay fever and asthma. Intake of alcohol, but not ever-drinking, was significantly associated with increasing serum total IgE and log (total IgE) (Fig. 3) .
Mendelian randomization analysis
The rs1229984 genotype associated with higher alcohol intake (major homozygotes versus minor homozygotes and heterozygotes) was not significantly associated with hay fever, asthma, allergic sensitization or log (total IgE) in ever-or non-drinkers (Supporting information, Figs S2-S5).
The estimate for the first-stage regression (SNP-exposure) among ever-drinkers (calculated in the UK Biobank data) was β = 1.324 [standard error (SE) = 0.086, n = 292 158] units of alcohol for alcohol-increasing genotype versus alcohol-decreasing genotypes. The estimates for the second-stage regressions (SNP-outcome) were as follows: hay fever β = À0.130 (SE = 0.079); asthma β = À0.144 (SE = 0.086); allergic sensitization β = À0.038 (SE = 0.128); and log (total IgE) β = 0.062 (SE = 0.069).
There was no clear evidence that genetically assessed intake of alcohol was associated with risk of hay fever, asthma or allergic sensitization. The causal estimates per unit of alcohol consumed were an OR = 0.907 [95% confidence interval (CI) = 0.806,1.019; P = 0.101] for hay fever, an OR = 0.897 (95% CI = 0.790, 1.019; P = 0.095) for asthma and an OR = 0.971 (95% CI = 0.804, 1.174; P = 0.763) for allergic sensitization.
Genetically assessed higher alcohol intake was not associated with total IgE (Fig. 3) . The causal estimate of log (total IgE) for ever-drinkers was β = 0.047 (95% CI = -0.055, 0.149; P = 0.366) per unit of alcohol, which reflects an approximate 4.7% change (95% CI = -5.5%, 14.9%; P = 0.366) in total IgE per unit of alcohol consumed (Fig. 3) .
Analyses included UK Biobank data and 1958 BC where the alcohol genotype was directly genotyped, and adjustments made for principal components (Supporting information, Figs S1-S5) led to similar conclusions.
The primary definition of hay fever in UK Biobank suggested an OR = 0.987 (95% CI = 0.952, 1.023, P = 0.474, n = 394 883) for ever-drinkers with alcohol increasing genotype. Using self-reported hay fever medication as alternative definition of hay fever (see Supporting information) suggested an OR = 0.977 (95% CI = 0.876, 1.089, P = 0.671, n = 394 883). Using self-reported hay fever classified as serious illness as alternative definitions of hay fever suggested an OR = 1.011 (95% CI = 0.934, 1.093, P = 0.793, n = 394 883). Hay fever in UK Biobank without the UK Biobank Lung Exome Variant Evaluation (UK BiLEVE) study [36] (see Supporting information) suggested an OR = 0.984 (95% CI = 0.947, 1.022, P = 0.398, n = 351 833).
Asthma in the UK Biobank without BiLEVE suggested an OR = 0.989 (95% CI = 0.939, 1.041, P = 0.666, n = 351 833), whereas asthma in the entire UK Biobank suggested an OR = 0.995 (95% CI = 0.949, 1.044, P = 0.845, n = 394 883) for the alcohol increasing genotype. 
DISCUSSION
We found that ever-drinking was observationally positively associated with hay fever and inversely with asthma, but there was no clear evidence of association with allergic sensitization or total IgE, and in Mendelian randomisation analyses genetically assessed intake of alcohol was not associated with hay fever, asthma, allergic sensitization or serum total IgE, suggesting that the observational associations are not causal. Figure 2 Random-effects meta-analyses of observational and instrumental variable estimates of the sex-and age-adjusted associations of alcohol status and intake and genetically assessed alcohol intake, respectively, and hay fever, asthma and allergic sensitization (see heterogeneity in Supporting information, Figs 2-4 and 6-8). Numbers in the instrumental variable analyses refer to SNP-exposure and SNP-outcome associations, respectively. CI = confidence interval; SNP = single nucleotide polymorphism
Oldenburg et al. found that alcohol feeding decreased airway hyper-responsiveness and allergic airway inflammation in allergic mice, suggesting that there may be an important role for alcohol in the modulation of asthma [37] . Few studies have examined the possible bronchodilator effect of alcohol in humans [38, 39] . Ayres et al. found that intake of 40 ml of sherry was consistent with an increase in peak expiratory flow rate in 19 patients with asthma but not in 16 controls [39] . This bronchodilation was more marked in patients with a peak flow rate less than 50% of the predicted rate. Lieberoth et al. found that alcohol intake was associated with incident asthma in adults with a U-shaped association, where the lowest risk of asthma was observed in the group with a moderate intake of alcohol [40] . There is evidence that acetaldehyde increases histamine release from mast cells in both animal and human studies [10] . In Japanese populations, in which a genetic variant causing high levels of acetaldehyde is extremely common, in these genetically predisposed individuals alcohol is accompanied by bronchoconstriction and flushing (alcohol-induced asthma and Oriental flushing) following alcohol intake. Whether the alcohol-induced Th2-skewing of the human immune response is mediated through acetaldehyde is not fully known.
A study by Siu et al. found that light to moderate alcohol drinkers had better lung function than did abstainers. This was independent of smoking and evident lung or heart disease, suggesting that drinking moderate amounts of alcohol may benefit lung function [41] . Frantz et al. found that alcohol, and heavy drinking in particular, had a negative effect on lung function in smokers [42] . However, Sparrow et al. found that alcohol consumption was not associated with baseline or follow-up levels of forced expiratory volume in one second (FEV 1 ) or forced vital capacity (FVC) in 1067 men [43] .
Several cross-sectional studies have reported a positive association between alcohol intake and allergic sensitization [9, 11, 12] . However, Assing et al. found no association between alcohol intake and skin prick test positivity among 1668 students [8] . The association between alcohol intake and incident allergic sensitization in cohort studies is even more controversial [6, 15] . In a study of 5870 women aged 20-29 years, Bendtsen et al. [16] found that self-reported alcohol consumption was positively associated with the risk of developing perennial allergic rhinitis but not seasonal allergic rhinitis. The association of moderate and excessive alcohol intake with higher serum levels of total IgE is more consistent [4] [5] [6] 9, 12, 13] . A high consumption of alcohol may also increase IgE sensitization to crossreactive carbohydrate determinants, and specific IgE results should be interpreted with caution in heavy alcohol drinkers [44] . In addition, experimental alcohol administration to rodents induces an increase of serum IgE concentrations [19] . Moreover, cessation of alcohol consumption in heavy drinkers is followed shortly by a decrease of serum IgE concentrations [4, 13] . In a Mendelian randomization study of 111 408 people from the general population, Nordestgaard et al. found that genetically assessed higher alcohol intake was positively associated with total IgE (but not with allergic disease) [45] .
In accordance with previous studies, we found that the rs1229984 was strongly associated with drinking status and alcohol intake, which shows that rs1229984 is well-suited as a genetic instrument of alcohol intake [20] . We used a standardized analytical protocol to increase reliability and robustness of the findings. To avoid confounding by population stratification, we included Europeans only and adjusted for population structure using principal components when possible. As this covered most of the participants, we regard confounding by stratification to be of minor concern. We used objective markers of allergic sensitization, serum total IgE and lung function, which may be more reliable than self-reported measures in certain situations. Using Mendelian randomization has several shortcomings, e.g. the observational analysis of ever-versus never-drinkers cannot be mimicked using this approach. As the genotype explains only a small part of the variation in alcohol consumption, Mendelian randomization has lower power than traditional Figure 3 Random-effects meta-analyses of observational and instrumental variable estimates of the sex-and age-adjusted and sex-stratified associations of alcohol status and intake and genetically assessed alcohol intake, respectively, and serum total immunoglobulin (Ig)E (see heterogeneity in Supporting information, Figs 5 and 9) . Numbers in the instrumental variable analyses refer to SNP-exposure and SNP-outcome associations, respectively. CI = confidence interval; SNP = single nucleotide polymorphism observational studies for comparable study sizes, i.e. Mendelian randomization studies need very large samples to be adequately powered. A limitation of the study is the use of mainly self-reported hay fever and asthma rather than clinical diagnoses or measurements. A non-differential misclassification of a binary outcome is likely to attenuate associations towards the null. We also defined alcohol consumption from self-report, but the validity compared with alternative measurements has previously been found to be reasonable [46] . The hay fever variable in the UK Biobank included eczema. Therefore, we assessed two additional hay fever variables from the UK Biobank with similar results, which indicates that the misclassification did not substantially bias our results. The main weaknesses of the additional hay fever variables were that one was measured at follow-up in 2015 and in a subgroup only, limiting the available sample size; the other was based on self-reported medication rather than doctor-diagnosed hay fever. Of note, alcohol intake did not distinguish between, e.g. beer and wine. We may have lacked power to show a similar association between alcohol and serum total IgE. It would be of interest to also study extreme exposure to alcohol, as seen in alcoholics. However, such individuals would also differ more substantially from the rest of the population with regard to potential confounders such as genetics of alcohol dependence and socioeconomic factors. The present study focused on exposure levels in the normal range and in a population-based setting. It is important to acknowledge that the present study does not investigate effects of exposure to alcohol in childhood before alcohol use, and thus only relates to cases of asthma/hay fever that develop after start of alcohol use. However, it is being increasingly recognized that many cases of hay fever and asthma have their onset in adolescence or later in adulthood. Moreover, a factor that exacerbates or influences duration of a disease could also increase the prevalence of disease.
In conclusion, observational analyses found that everdrinking versus non-drinking was positively associated with hay fever and inversely with asthma, but not with allergic sensitization and serum total IgE. In contrast, genetic predisposition to consume more alcohol did not affect risk of hay fever, asthma, allergic sensitization or serum levels of total IgE. The discrepancy of results between observational and Mendelian randomization analyses could be due to potential residual confounding, e.g. by socioeconomic or life-style factors. Our results challenge the concept of a risk-increasing effect of alcohol consumption on allergic disease and asthma.
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